4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-25-110773
President & CEO sold 1,573 shares at $26.59 ($41,826)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2025-08-19 | Sale | −1,573 | $26.59 | $41,826 | 69,340 | D: show line 1 in the form |
| Open-market sales · 1,573 sh · avg $26.59 · $41,826 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2025-08-19 | Grant or award · Stock Option | +86,666 | 86,666 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…